Synopsis
0
EU WC
0
KDMF
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
99
PharmaCompass offers a list of Alimemazine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Alimemazine manufacturer or Alimemazine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Alimemazine manufacturer or Alimemazine supplier.
PharmaCompass also assists you with knowing the Alimemazine API Price utilized in the formulation of products. Alimemazine API Price is not always fixed or binding as the Alimemazine Price is obtained through a variety of data sources. The Alimemazine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Alimemazine Tartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Alimemazine Tartrate, including repackagers and relabelers. The FDA regulates Alimemazine Tartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Alimemazine Tartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Alimemazine Tartrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Alimemazine Tartrate supplier is an individual or a company that provides Alimemazine Tartrate active pharmaceutical ingredient (API) or Alimemazine Tartrate finished formulations upon request. The Alimemazine Tartrate suppliers may include Alimemazine Tartrate API manufacturers, exporters, distributors and traders.
click here to find a list of Alimemazine Tartrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Alimemazine Tartrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Alimemazine Tartrate active pharmaceutical ingredient (API) in detail. Different forms of Alimemazine Tartrate DMFs exist exist since differing nations have different regulations, such as Alimemazine Tartrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Alimemazine Tartrate DMF submitted to regulatory agencies in the US is known as a USDMF. Alimemazine Tartrate USDMF includes data on Alimemazine Tartrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Alimemazine Tartrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Alimemazine Tartrate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Alimemazine Tartrate Drug Master File in Japan (Alimemazine Tartrate JDMF) empowers Alimemazine Tartrate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Alimemazine Tartrate JDMF during the approval evaluation for pharmaceutical products. At the time of Alimemazine Tartrate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Alimemazine Tartrate suppliers with JDMF on PharmaCompass.
A Alimemazine Tartrate CEP of the European Pharmacopoeia monograph is often referred to as a Alimemazine Tartrate Certificate of Suitability (COS). The purpose of a Alimemazine Tartrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Alimemazine Tartrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Alimemazine Tartrate to their clients by showing that a Alimemazine Tartrate CEP has been issued for it. The manufacturer submits a Alimemazine Tartrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Alimemazine Tartrate CEP holder for the record. Additionally, the data presented in the Alimemazine Tartrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Alimemazine Tartrate DMF.
A Alimemazine Tartrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Alimemazine Tartrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Alimemazine Tartrate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Alimemazine Tartrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Alimemazine Tartrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Alimemazine Tartrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Alimemazine Tartrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Alimemazine Tartrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Alimemazine Tartrate suppliers with NDC on PharmaCompass.
Alimemazine Tartrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Alimemazine Tartrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Alimemazine Tartrate GMP manufacturer or Alimemazine Tartrate GMP API supplier for your needs.
A Alimemazine Tartrate CoA (Certificate of Analysis) is a formal document that attests to Alimemazine Tartrate's compliance with Alimemazine Tartrate specifications and serves as a tool for batch-level quality control.
Alimemazine Tartrate CoA mostly includes findings from lab analyses of a specific batch. For each Alimemazine Tartrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Alimemazine Tartrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Alimemazine Tartrate EP), Alimemazine Tartrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Alimemazine Tartrate USP).
